Register for email alerts and news feeds:
This journal | BMJ Group
rss
Journal of Epidemiology and Community Health 2008;62:314-317; doi:10.1136/jech.2007.066423
Copyright © 2008 by the BMJ Publishing Group Ltd.

EVIDENCE-BASED POLICY AND PRACTICE

Using national health weeks to deliver deworming to children: lessons from Mexico

A Flisser1, J L Valdespino2, L García-García3, C Guzman4, M T Aguirre4, M L Manon4, G González-González4 and T W Gyorkos5

1 Departamento de Microbiología y Parasitología, Facultad de Medicina, Universidad Nacional Autonoma de México, Ciudad Universitaria, San Ángel, México
2 Laboratorios de Biológicos y Reactivos de Mexico, Secretaría de Salud, Mexico DF, Mexico
3 Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico
4 Instituto de Diagnóstico y Referencia Epidemiológicos (INDRE), México DF, México
5 Division of Clinical Epidemiology, McGill University Health Centre, McGill University, Montreal, Québec, Canada

Correspondence to:
Dr Ana Flisser, Departamento de Microbiología y Parasitología, Facultad de Medicina, UNAM, Ciudad Universitaria, San Ángel, México 04510 DF, Mexico; flisser{at}servidor.unam.mx

Mexico established national health weeks (NHWs) in the early 1980s to promote childhood vaccinations. Because of the cumulative worldwide peer-reviewed scientific evidence, the recommendations of the World Health Organization and other international organisations, the political will of the Mexican government and the infrastructure provided by the NHWs, deworming was added to the NHWs in 1993. In addition to the Ministry of Health, several other government organisations participated in administering the deworming component. Tens of millions of school-age and preschool children between the ages of 2 years and 14 years now receive deworming (a single 400 mg dose of albendazole) approximately every 8 months. Between 1993 and 1998 evaluations were carried out in over 90 000 children to determine the effect of NHWs on the prevalence of geohelminth infections. In 1993, the overall prevalence of Ascaris was 20% and that of Trichuris was 15%. Prevalences decreased significantly over time (p <0.001). Treatment efficacy for Ascaris ranged from 91.6% to 85.3%, and for Trichuris, from 97.9% to 42.6%. In 1998, after conducting 12 NHWs with deworming, the respective prevalences were Ascaris 8% and Trichuris 11%. The experience of Mexico in integrating albendazole into its NHWs shows how deworming can be delivered to large numbers of at-risk children using an existing infrastructure. The NHW approach may be generalisable in other countries with successful national vaccination campaigns. The challenge remaining is to sustain the deworming programme until other longer-term behavioural, environmental and socioeconomic changes can be implemented.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

In this issue
Carlos Alvarez-Dardet and John Ashton
J Epidemiol Community Health 2008 62: 281. [Extract] [Full Text] [PDF]

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest infectious diseases and epidemilogy jobs

Infectious diseases and epidemilogy jobs